You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

The COVID-19 Pandemic: European Situation Update

  • Authors: Matteo Bassetti, MD, PhD
  • CME / ABIM MOC Released: 6/12/2020
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 6/12/2021
Start Activity


Target Audience and Goal Statement

This activity is intended for an international audience of healthcare professionals, specifically infectious disease (ID) specialists.

The goal of this activity is to update physicians on the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Europe.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Current status of the COVID-19 pandemic in Europe
    • Impact of different measures such as testing on SARS-CoV-2 spread


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Matteo Bassetti, MD, PhD

    Professor of Infectious Diseases
    Department of Health Science
    University of Genoa
    Head, Infectious Diseases Clinic
    Hospital Policlinico San Martino -- IRCCS
    Genoa, Italy

    Disclosures

    Disclosure: Matteo Bassetti, MD, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Achaogen; Angelini; Astellas; Bayer; Basilea; BioMérieux; Cidara; Gilead; Menarini; MSD; Nabriva; Paratek; Pfizer; Roche; Melinta; Shionogi; Tetraphase; VenatoRx; Vifor
    Served as a speaker or a member of a speakers bureau for: Achaogen; Angelini; Astellas; Bayer; Basilea; BioMérieux; Cidara; Gilead; Menarini; MSD; Nabriva; Paratek; Pfizer; Roche; Melinta; Shionogi; Tetraphase; VenatoRx; Vifor
    Received grants for clinical research from: Angelini; Basilea; Astellas; Shionogi; Cidara; Melinta; Gilead; Pfizer; MSD
    Owns stock, stock options, or bonds from: Nabriva; Tetraphase

Editor

  • Shanthi Voorn, PhD

    Medical Education Director, WebMD Global, LLC

    Disclosures

    Disclosure: Shanthi Voorn, PhD, has disclosed no relevant financial relationships.

CME Reviewer

  • Robert Morris, PharmD

    Associate CME Clinical Director, Medscape, LLC

    Disclosures

    Disclosure: Robert Morris, PharmD, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements


 

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

The COVID-19 Pandemic: European Situation Update

Authors: Matteo Bassetti, MD, PhDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 6/12/2020

Valid for credit through: 6/12/2021

processing....

Note: The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. As of October 22, 2020, the US Food and Drug Administration has approved Remdesivir for use in adult and pediatric patients 12 years and older and weighing 40 kg for the treatment of COVID-19 requiring hospitalization.

 

 

  • Print